For the year ending 2025-12-31, IGC has $9,712K in assets. $2,289K in debts. $900K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 900 | |||
| Accounts receivable, net | 12 | |||
| Inventory | 640 | |||
| Short-term investment | 38 | |||
| Asset held for sale | 0 | |||
| Deposits and advances | 200 | |||
| Total current assets | 1,790 | |||
| Intangible assets, net | 5,101 | |||
| Property, plant and equipment, gross | 3,811 | |||
| Less accumulated depreciation | 1,670 | |||
| Property, plant and equipment, net | 2,141 | |||
| Claims and advances | 669 | |||
| Operating lease asset | 11 | |||
| Total non-current assets | 7,922 | |||
| Total assets | 9,712 | |||
| Accounts payable | 1,014 | |||
| Accrued liabilities and others | 1,142 | |||
| Total current liabilities | 2,156 | |||
| Long-term loans | 131 | |||
| Other liabilities | 0 | |||
| Operating lease liability | 2 | |||
| Total non-current liabilities | 133 | |||
| Total liabilities | 2,289 | |||
| Common stock and additional paid-in capital, 0.0001 par value 600,000,000 shares authorized 95,038,026 and 80,878,058 shares issued and outstanding as of december 31, 2025, and march 31, 2025, respectively | 138,014 | |||
| Accumulated other comprehensive loss | -5,701 | |||
| Accumulated deficit | -124,890 | |||
| Total stockholders equity | 7,423 | |||
| Total liabilities and stockholders equity | 9,712 | |||
IGC Pharma, Inc. (IGC)
IGC Pharma, Inc. (IGC)